Delivery Order SPE2DB20D6037-SPE2DB22FC9VZ

Award Date 2/15/22
Potential Completion Date 2/16/22
Potential Value $3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,079.88 contract was issued by the Defense Logistics Agency (DLA) Medical Supply Chain division to provide Sumatriptan 20 mg nasal sprays. The delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to $499,999,999, which allows the DLA to issue orders for a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,884.91, is for the delivery of 4,565,607,297 units of Sumatriptan 20 mg nasal sprays. The award is part of a larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which allows the agency to issue firm fixed-price delivery orders for a...
This federal contract award was issued by the Defense Logistics Agency (DLA) under the Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,312.24 firm fixed-price delivery order is for the supply of 4564687136 units of 20 mg sumatriptan nasal sprays. This award is under a larger indefinite delivery contract (IDC) valued up to $499,999,999 held by DMS Pharmaceutical Group with the DLA. The...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The $5,744.83 contract is for the delivery of Sumatriptan 20 mg nasal sprays, with a completion date of January 29, 2024. DMS Pharmaceutical Group holds a broader indefinite delivery contract with DLA, contract 4600082013 under the SPE2DB program, valued at up to $4,999,999 through 2025, to provide a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $1,711.35, is for the provision of Imitrex 6 mg/0.5 ml pen injectors to support the recurring medical supply needs of military healthcare facilities. The contract is not associated with any set-aside designation. DMS Pharmaceutical Group holds a significant single-award Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,458.54 firm fixed-price delivery order is for the supply of Sumatriptan Succinate, a specialized pharmaceutical product, with a performance period through November 15, 2024. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the...
This federal contract award was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $1,933.95, is for the delivery of sumatriptan succinate, a pharmaceutical product. This is a firm fixed-price delivery order contract with no set-aside designation. The contract is part of a larger indefinite delivery contract (IDC) awarded to DMS...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,301.50 firm fixed-price contract is for the delivery of SUMATRIPTAN 6 MG/0.5 ML INJECT 0.5ML medication, with a completion date of June 20, 2023. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with DLA under the SPE2DB program, valued at up to $499,999,999, which allows the DLA to issue...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,640.15 firm fixed-price delivery order is for the supply of Sumatriptan Succinate, a prescription medication. The contract does not have a set-aside designation. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,891.02 firm fixed-price delivery order is for the supply of Sumatriptan Succinate, a prescription medication used to treat migraine headaches. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue...
  • SPE2DB20D6037
    Indefinite Delivery Contract
  • SPE2DB20D6037-SPE2DB22FC9VZ
    Delivery Order

This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order worth $2,984.80 for IMITREX 20 MG NASAL SPRAYS. The contract was awarded on February 15, 2022, with a completion date of February 16, 2022.

The contract is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation. DMS Pharmaceutical Group Inc. is a pharmaceutical wholesaler that specializes in providing a wide range of pharmaceutical products and medical supplies to the U.S. federal government, primarily serving the Department of Defense (DoD) and Department of Veterans Affairs (VA).

This contract is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group Inc. and the DLA under the SPE2DB program, valued at up to $499,999,999 and running through December 31, 2025. This IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide.

Generated 10/23/24, 9:47 AM